Procedure
Near-Infrared Fluorescence Imaging
Near-Infrared Fluorescence Imaging is a medical procedure with 3 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
PROCEDURE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
2
67%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 1Safety & dosage
2(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Recruiting2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 12 (100.0%)
Trials by Status
recruiting267%
completed133%
Recent Activity
2 active trials
Showing 3 of 3
recruitingphase_1
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
NCT03582124
recruitingphase_1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
NCT03510208
completed
Lymphatic Function in Patients With a Fontan Circulation From Brazil
NCT04394507
Clinical Trials (3)
Showing 3 of 3 trials
NCT03582124Phase 1
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
NCT03510208Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
NCT04394507
Lymphatic Function in Patients With a Fontan Circulation From Brazil
All 3 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 3